@AsherElad I switched to Prasugrel right after the publication of the ISAR-REACT 5 and never looked back. Just can't understand why and how people keep pushing Ticagrelor other than $$$
@SamaHoole When earn more money they get access to health care, to clean water, to better sanitary, to antibiotics, to more food in general, to more security, etc. This univariate correlation in such ultra complex equation is one of the dumbest things to say. The result is multivariable
@MAnisHaider A significant limitation is that the comparison was not against the S3 Ultra Resilia (which had not been released by the time of the trial).
@davidasinclair Time to run a properly sized randomized clinical trial with long follow-up, such as the ones that showed iSGLT2 can safely and effectively protect the kidneys.
@DFCapodanno I quit using ticagrelor when ISAR-REACT 5 was out. Way back there. I really don't understand why people kept pushing on ticagrelor. The data was not good plus patients had to take it twice a day and a good part of them complained of shortness of breath.
@janvankeer@drjohnm What is the point of small studies if the results shown are simply not true and biased. In this case, it would be much better to just publish the treatment arm. Why comparing things that can't be compared?
@VascodaGama Mais um ano zicado. Time pode jogar bem que alguma coisa acontece pra perder ou empatar. Ninguém nos salva da série B em 2026 infelizmente